Biotechnology in the Age of COVID-19 Webinar: Biopharmaceutical Business Continuity in the COVID-19 Era
As COVID-19 spread worldwide in 2020, biomanufacturing supply chains have come under increasing pressure, with areas of concern including shortages of raw materials, geographical barriers to distribution, and competition. Business continuity may also be impacted by factors such as the rapid redirection of resources toward development and manufacturing of COVID-19 vaccines, adjuvants, or therapeutics. Maintaining biomanufacturing continuity in the face of these challenges is vitally important. During this webinar, industry will share their experiences on issues encountered in accessing materials or services needed to maintain manufacturing operations and their strategic responses to these supply chain challenges. We will also hear about ensuring business continuity and discuss what we have learned from COVID-19 that can enhance industry response to future pandemics.
This webinar is the third in our ‘Biotechnology in the Age of COVID-19’ Webinar series, formed to address issues around the biopharmaceutical industry’s multifaceted response to the pandemic, and its impact on manufacturing operations.